About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Ohio | 28,681 Studies Near You

Clinical TrialsOhio

Clinical Trials in Ohio

Discover 28,681 clinical trials near Ohio. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1541-1560 of 28,681 trials

CompletedMethylphenidate in Children and Adolescents With Pervasive Developmental DisordersThis study will evaluate the efficacy and safety of methylphenidate for treating hyperactivity, impulsiveness, and distractibility in 60 children and adolescents with Pervasive…NCT00025779·Los Angeles, California and 4 others CompletedA Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's DiseaseThe main aim of the study is to check for long-term side effects of Vedolizumab Subcutaneous (also known as Vedolizumab SC) in people with ulcerative colitis (UC) and Crohn's…NCT02620046·Phoenix, Arizona and 300 others

Find Trials by Condition in Ohio

Breast Cancerin Ohio Lung Cancerin Ohio Prostate Cancerin Ohio Colorectal Cancerin Ohio Melanomain Ohio Leukemiain Ohio Lymphomain Ohio Pancreatic Cancerin Ohio Ovarian Cancerin Ohio Brain Cancerin Ohio Diabetesin Ohio

Data from ClinicalTrials.govTerms

CompletedOpioid-induced Bowel Dysfunction: Pivotal Assessment of LubiprostoneThe primary purpose of this study is to evaluate the efficacy and safety of lubiprostone administration in patients with Opioid-induced Bowel Dysfunction.NCT00595946·Birmingham, Alabama and 94 others

CompletedAn Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 MonthsThe primary objective is to evaluate the safety of long-term treatment with NP101 as assessed by: * Subject self-examination skin irritation scores * Adverse events * Changes in…NCT00792103·Phoenix, Arizona and 33 others

Active not recruitingTORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid TumorsThis phase I trial studies the side effects and best dose of raptor/rictor-mammalian target of rapamycin (mTOR) (TORC1/2) inhibitor MLN0128 when given in combination with…NCT02142803·Boston, Massachusetts and 2 others

CompletedLong Term Safety of Tobramycin Inhalation Powder in Patients With Cystic FibrosisThis study assessed the long term safety data for the use of tobramycin inhalation powder in patients suffering from cystic fibrosis who have a chronic pulmonary infection with…NCT01519661·Little Rock, Arkansas and 48 others

CompletedHealthy Start to Feeding InterventionThe current study will test the impact of a 3-session obesity prevention program targeting healthy introduction of solid foods in infancy on growth trajectories, appetite…NCT03597061·Cincinnati, Ohio

CompletedFilgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's DiseaseThe primary objectives of this study are to evaluate the safety and efficacy of filgotinib during induction and maintenance treatment of moderately to severely active Crohn's…NCT02914561·Dothan, Alabama and 512 others

CompletedAlisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the UterusThis phase II trial studies how well alisertib works in treating patients with leiomyosarcoma of the uterus that has come back or persistent.NCT01637961·Hartford, Connecticut and 49 others

CompletedSafety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular DegenerationThis is a safety and efficacy study of abicipar pegol in participants with neovascular age-related macular degeneration.NCT02462486·Birmingham, Alabama and 186 others

RecruitingRecruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell DiseaseThe goal of this observational study is to help us understand more about the best ways to help individuals living with Sickle Cell Disease (SCD) get the best care.NCT06385886·Birmingham, Alabama and 8 others

WithdrawnLapatinib Resistance in Patients With Breast CancerRATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about cancer and the development of drug resistance…NCT00898573·Cleveland, Ohio and 8 others

CompletedTo Study the Efficacy & Safety of Oral NA-921 (Bionetide) in Girls and Women with Rett SyndromeTo study the efficacy \& safety of oral Bionetide versus placebo in girls and women with Rett syndromeNCT06849973·La Jolla, California and 15 others

CompletedA Study to Assess the Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of 2-Week Treatment With Inhaled AZD7594 in Adolescents (12 to 17 Years) With AsthmaThis is an open-label, multi-centre, Phase I study to assess the PK, PD and safety of 2 week treatment with inhaled AZD7594 in adolescent patients with asthma.NCT03976869·Rolling Hills Estates, California and 9 others

Active not recruitingSafety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAHThe purpose of this study is to deliver nimodipine via IV directly into the bloodstream and to determine if this is as safe and tolerable as oral nimodipine capsules.NCT05995405·Birmingham, Alabama and 21 others

CompletedSafety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive EsophagitisThe purpose of this study is to assess the efficacy and safety of 8 weeks of daily treatment with Ilaprazole (5, 20 and 40 mg), once daily (QD), compared to lansoprazole 30 mg in…NCT00471094·Hueytown, Alabama and 93 others

TerminatedFlotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)Open-label, multi-dose, single-arm, multi-center, Phase 1/2 study conducted in three segments: the Single Patient Dose Escalation Segment (complete), followed by the Multi-Patient…NCT02152956·Duarte, California and 42 others

CompletedPhase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie Diet1.NCT00747929·Mobile, Alabama and 37 others

CompletedEvaluation of Daily Disposable Toric Soft Lenses Manufactured With an Alternative Hydration ProcessThis is a prospective, multi-site, dispensing, randomized, controlled, double-masked, bilateral wear, 2x2 crossover study to evaluate the safety and effectiveness of the test lens.NCT06967129·Mission Viejo, California and 19 others

CompletedEndoscopic Esophageal Topography (Endoflip 2.0) Versus High-resolution Manometry (HRM)The purpose of the study is to investigate the use of FLIP topography in patients undergoing evaluation for gastroesophageal reflux disease (GERD).NCT05089929·Columbus, Ohio

PreviousPage 78 of 1435Next

Heart Diseasein Ohio